Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 92 clinical trials
Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

previous research, we will carry out the pretreatment regimen of decitabine + cytarabine in elderly patients with AML who have achieved disease treatment through induction therapy, and continue the

cytarabine
remission
neoadjuvant therapy
consolidation therapy
decitabine
  • 0 views
  • 03 Feb, 2022
  • 1 location
Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

cumulative relapse rate of 50-80%. Decitabine has been demonstrated efficacy in the treatment of patients with recurrent or refractory leukemia and myelodysplastiv syndrome. It was reported that the

cyclophosphamide
residual tumor
ara-c
cell transplantation
acute leukemia
  • 2 views
  • 01 Mar, 2022
  • 1 location
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission [CR], Complete Remission

leukapheresis
remission
venetoclax
refractory acute myeloid leukemia (aml)
blast cells
  • 4 views
  • 23 Mar, 2022
  • 6 locations
Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia

This phase I trial studies the side effects and best dose of palbociclib when given alone and in combination with sorafenib, decitabine, or dexamethasone in treating patients with leukemia that

ejection fraction
decitabine
hydroxyurea
  • 84 views
  • 28 Jan, 2022
  • 1 location
Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of Sintilimab in combination with decitabine in the treatment of Relapsed/Refractory or advanced NK/T-cell lymphoma patients

renal function
  • 0 views
  • 25 Jan, 2021
  • 1 location
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

This phase II trial studies how well decitabine with ruxolitinib or fedratinib works before hematopoietic stem cell transplant in treating patients with accelerated/blast phase

leukapheresis
myeloproliferative/myelodysplastic disorders
hemolysis
leukostasis
polycythemia vera
  • 14 views
  • 08 Mar, 2022
  • 1 location
Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor

the treatment with chidamide in combination with decitabine.

hodgkin's disease
monoclonal antibodies
  • 1 views
  • 03 Mar, 2022
  • 1 location
Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

and myelodysplastic syndrome. Unfortunately, some patients relapsed after allo-HSCT. In this prospective randomized controlled study, the safety and efficacy of Decitabine + BUCY and BUCY

  • 0 views
  • 23 Jan, 2021
  • 1 location
Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

myelodysplastic syndrome. Unfortunately, some patients relapsed after allo-HSCT. In this prospective randomized controlled study, the safety and efficacy of Decitabine + BUCY and BUCY myeloablative conditioning

  • 0 views
  • 23 Jan, 2021
  • 1 location
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

This phase Ib trial is to find out the best dose decitabine/cedazuridine and possible benefits and/or side effects of decitabine/cedazuridine and enzalutamide in treating patients with castrate

  • 0 views
  • 09 Mar, 2022
  • 1 location